Ming Chen

Associate Professor, @DukePathDept, Cancer Researcher, Animal Lover

[Ming Chen @MingChen03]

Pleased to share our paper showing that suppression of lipid biosynthesis may potentially improve the efficacy of chemotherapy against human prostate cancer. @DukePathDept @DukeMedSchool @DukeCancer

https://t.co/QHc3fuI8sB

[Ming Chen @MingChen03]

Pleased to share our review about lipid nanoparticle-based mRNA vaccines in cancer.
https://t.co/OKxJUa1BTN @DukePathDept @DukeMedSchool @DukeCancer

[Ming Chen @MingChen03]

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer - https://t.co/y2liHY5veV We commented on an article by Zhang et al. showing mitochondrial ETC as a potential vulnerability for targeted therapies in CDK12-mutant prostate cancer; #Commentary

[Ming Chen @MingChen03]

@pandayarvind441 @MayoClinic @MayoCancerCare Awesome, Arvind! Look forward to exciting work coming out of your lab.

[Ming Chen @MingChen03]

@neurogiselle Congrats, Giselle! Well-deserved!

[Ming Chen @MingChen03]

Cholesterol deficiency in intratumoral cytotoxic T cells limits their anti-tumor activity @Cancer_Cell @ChenqiXuSH
https://t.co/zfFNRYEKh0

[Ming Chen @MingChen03]

Please also check out this fantastic commentary from @yu_jindan and colleagues.

https://t.co/NBI3jq3bTo

[Journal of Clinical Investigation @jclinicalinvest]

Ferroptosis limits aggressiveness of RB1-deficient prostate cancer via E2F/ACSL4: https://t.co/ZWYSfY5KTi
@DukeMedSchool
#Oncology

[Ming Chen @MingChen03]

@YaruiDiao @DukePathDept @DukeCancer @gaziou @AarmstrongDuke Thank you, Yarui.

[Ming Chen @MingChen03]

Excited to share our paper spearheaded by my postdoc Mu-En Wang, detailing how RB1 loss leaves cancer cells susceptible to ferroptosis. Big thank you to our awesome collaborators, reviewers, and editor. https://t.co/AmJ9xc14jc @DukePathDept @DukeCancer @gaziou @AarmstrongDuke

[Ming Chen @MingChen03]

@DaphnaNachmani @DukePathDept @DukeCancer @gaziou @AarmstrongDuke Thanks, Daphna.

[Ming Chen @MingChen03]

@pandayarvind441 @DukePathDept @DukeCancer @gaziou @AarmstrongDuke Thank you, Arvind.

[Ming Chen @MingChen03]

@DukePathDept @DukeCancer @gaziou @AarmstrongDuke Thank you @yu_jindan for your thoughtful commentary on our paper.
https://t.co/NBI3jq3bTo

[Ming Chen @MingChen03]

@YaruiDiao @MolecularCell Well-deserved, Yarui! Congrats to you and your team!

[Ming Chen @MingChen03]

@MartinaSarchi @Doulatov_lab @unipv Congrats, Martina! That’s awesome 👏👏

[Ming Chen @MingChen03]

@The_Ito_Lab @ISEHSociety @MilsomMick @krikirschner Great news. Well deserved, Keisuke!

[Ming Chen @MingChen03]

Pall of suspicion by
@jeffmervis: NIH’s secretive "China initiative” has upended hundreds of lives and destroyed scores of academic careers https://t.co/KolupTCCKI

[Duke University School of Medicine @DukeMedSchool]

A team led by @DukePathDept chair Jiaoti Huang, MD, PhD, found glypican-3, a protein on the surface of neuroendocrine #prostatecancer cells provides a better opportunity for targeting cells that are intrinsically resistant to hormonal therapy. @DukeCancer
https://t.co/AQNcbDn2Fb

[DukePathDept @DukePathDept]

Check out our PhD Graduate program, which gives students the unique ability to do research in the basic sciences as well as in the translational sciences. https://t.co/ca7jgnUdnX via @YouTube

[Ming Chen @MingChen03]

@NeuroEpi_CIBio @NAR_Open @CIBIO_UniTrento @TalkowskiLab @IFOMresearch @mikeyab6872 @SGustincich Congrats, Marta. Great work!

[Ming Chen @MingChen03]

Exciting project and amazing PI!

[Daphna Nachmani @DaphnaNachmani]

Please RT 🎉🎉🎉
Join us to understand how the ribosome dictates cell identity, focusing on hematopoiesis and leukemia. We're studying cell identity in-vivo and developing new and amazing tools!
Fully funded @ERC_Research positions - postdocs and PhDs.
https://t.co/c3YeUCSEVt